The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8+ T cells via TLR4 signaling
Open accessAbstract
Lymphodepletion with total body irradiation (TBI) increases the efficacy of adoptively transferred tumor-specific CD8(+) T cells by depleting inhibitory lymphocytes and increasing homeostatic cytokine levels. We found that TBI augmented the function of adoptively transferred CD8(+) T cells in mice genetically deficient in all lymphocytes, indicating the existence of another TBI mechanism of action. Additional investigation revealed commensal gut microflora in the mesenteric lymph nodes and elevated LPS levels in the sera of irradiated mice. These findings correlated with increased dendritic cell activation and heightened levels of systemic inflammatory cytokines. Reduction of host microflora using antibiotics, neutralization of serum LPS using polymyxin B, or removal of LPS signaling components using mice genetically deficient in CD14 and TLR4 reduced the beneficial effects of TBI on tumor regression. Conversely, administration of microbial ligand-containing serum or ultrapure LPS from irradiated animals to nonirradiated antibody-lymphodepleted mice enhanced CD8(+) T cell activation and improved tumor regression. Administration of ultrapure LPS to irradiated animals further enhanced the number and function of the adoptively transferred cells, leading to long-term cure of mice with large B16F10 tumors and enhanced autoimmune vitiligo. Thus, disruption of the homeostatic balance between the host and microbes can enhance cell-based tumor immunotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“A number of studies have shown that the gut microbiome may influence anti-tumor immune responses via innate and adaptive immunity (11, 12)”
From Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients (2018) · cites this paper as [11]
In the citing paper
“In mouse models, certain gut commensals mediate efficacy of anticancer therapies, including chemotherapy, radiotherapy, and immunotherapies such as adoptive T cell transfer, intratumoral CpG-oligonucleotides, and ICIs.”
From Melanoma and microbiota: Current understanding and future directions (2024) · cites this paper as [2]
In the citing paper
“total-body irradiation, which enhanced the efficacy of tumor-specific T cell transfer through translocation of a bacterial product, the toll-like receptor 4L (TLR4L) lipopolysaccharide, from the intestinal lumen to secondary lymphoid organs (10).”
From The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies (2018) · cites this paper as [10]
In the citing paper
“administration of antibiotics significantly abrogated anti-tumor activity in a murine model of adoptive cell therapy for melanoma”
From The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy (2018) · cites this paper as Paulos et al., 2007
In the citing paper
“For example, the widely studied bacterial lipopolysaccharide (LPS), a major component of the outer membrane in gram-negative bacteria, activates the host’s cell surface receptor toll-like receptor 4 (TLR4), belonging to the family of pattern recognition receptors (PRRs), thus activating immune T cell-mediated response against cancer cells [40].”
From Gut Microbiota and Cancer: From Pathogenesis to Therapy (2019) · cites this paper as [40]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Janeway, C. A., & Medzhitov, R. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.083001.084359 · Cited by 8,394
Akira, S., & Takeda, K. (2004) · Nature reviews. Immunology · doi:10.1038/nri1391 · Cited by 8,312
Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene
Poltorak, A., He, X., Smirnova, I., Liu, M.-Y., Huffel, C. V., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., et al. (1998) · Science · doi:10.1126/science.282.5396.2085 · Cited by 7,631
A Toll-like receptor recognizes bacterial DNA
Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., et al. (2000) · Nature · doi:10.1038/35047123 · Cited by 6,491
Takeda, K., Kaisho, T., & Akira, S. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141126 · Cited by 6,143
Toll-like receptor control of the adaptive immune responses
Iwasaki, A., & Medzhitov, R. M. (2004) · Nature Immunology · doi:10.1038/ni1112 · Cited by 4,166
CD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding Protein
Wright, S. D., Ramos, R., Tobias, P. S., Ulevitch, R. J., & Mathison, J. C. (1990) · Science · doi:10.1126/science.1698311 · Cited by 3,996
Glucksberg, H., Storb, R. F., Fefer, A., Buckner, C. D., NEIMAN, P. E., Clift, R. A., Lerner, K. G., & Thomas, E. D. (1974) · Transplantation · doi:10.1097/00007890-197410000-00001 · Cited by 3,686
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
Brenchley, J. M., Price, D. A., Schacker, T. W., Asher, T. E., Silvestri, G., Rao, S., Kazzaz, Z., Bornstein, E., Lambotte, O., Altmann, D., et al. (2006) · Nature Medicine · doi:10.1038/nm1511 · Cited by 3,559
Approaching the asymptote? Evolution and revolution in immunology.Preprint
Janeway, C. (1989) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1989.054.01.003 · Cited by 3,396
Flagged first, then by citations
Research works printed but not linked: 1
- Caradonna, 2000, J. Endotoxin Res., 6, 205
Cited by
Sorted by citations
Items 501–581 of 581
Seo, I., Bae, S. U., Kim, S., Jeong, W. K., & Baek, S. K. (2019) · Journal of Bacteriology and Virology · doi:10.4167/jbv.2019.49.4.162 · Cited by 1
“마지막으로 CRT로 인한 직장암 점막의 파괴가 점막 미생물 의 전이 (translocation)를 유발하고 결과적으로 선천 면역에 영향을 주거나 (50), LPS-TLR4에 의한 APC의 활성화로 유도된 적응 면역의 조절을 유발할 수 있으므로 (51) 궁극적으로 CRT가 항암 면역 치료의 효과를 높이는 병합치료로 활용될 수 있는 근거가 마련될 것이다 (52).”
Microbiome: A Novel Therapeutics in Cancer Management
Oniyangi, A. G., & Nazir, A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819265-8.00004-8 · Cited by 1
Cisplatin-Induced Ototoxicity: Updates on Potential Molecular Mechanism
Jung, D. J. (2022) · Korean Journal of Otorhinolaryngology - Head and Neck Surgery · doi:10.3342/kjorl-hns.2022.00507 · Cited by 1
del Socorro, T. P., Tonneau, M., Pasquier, D., & Chamaillard, M. (2023) · The Cancer Journal · doi:10.1097/ppo.0000000000000652 · Cited by 1
Mechanism of Probiotic Action in Anticancer Immunity
Ragavan, M. L., & Das, N. (2023) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815124781123030005 · Cited by 1
Short Course in the Microbiome
Falana, K., Knight, R. D., Martin, C. R., Goldszmid, R. S., Greathouse, K. L., Gere, J., Young, H. A., & Kuo, W. P. (2015) · Journal of Circulating Biomarkers · doi:10.33393/jcb.2015.2058 · Cited by 1
Microbiome and Neurological Disorders
Ijaz, M. U., Akbar, A., Ashraf, A., Yeni, D. K., Naz, H. U., & Shahid, M. (2024) · Springer eBooks · doi:10.1007/978-981-97-3790-1_9 · Cited by 1
Kolb Consulting UG, M., Kolb, H., Weber, D., Simões, B. P., & Holler, E. (2018) · Cellular Therapy and Transplantation · doi:10.18620/ctt-1866-8836-2018-7-1-8-17 · Cited by 1
Canine Genetics, Health and Medicine
Rutland, C. S. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.92513 · Cited by 1
Role of microbiome in cancer immunotherapy
Russo, E., Boem, F., & Amedei, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823397-9.00010-7 · Cited by 1
DOW, S. W., & Guth, A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-59496-7.00014-1 · Cited by 1
Molecular Mimicry Between Tumor Associated Antigens and Microbiota-derived EpitopesPreprint
Ragone, C., Manolio, C., Mauriello, A., Cavalluzzo, B., Buonaguro, L., Tornesello, M. L., Tagliamonte, M., & Buonaguro, L. (2022) · Research Square · doi:10.21203/rs.3.rs-1753542/v1 · Cited by 1
Abbaszadeh, S. H., Yousefi, M., Arefhosseini, S. R., Mahmoodpoor, A., & Ebrahimi‐Mameghani, M. (2024) · Preprints.org · doi:10.20944/preprints202401.1988.v1 · Cited by 1
Employing T Cell Homeostasis as an Antitumor Strategy
Jensen, S. M., Paustain, C. C., & Fox, B. A. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8809-5_6
Microbial regulation of allergic inflammation
Hill, D. A. (2011) · Scholarly Commons (University of Pennsylvania)
Paschen, A. (2009) · doi:10.1002/9783527625970.ch1
Adoptiver Transfer tumorantigenspezifischer T-Zellen in der Onkologie
Mackensen, A. (2009) · Onkopipeline · doi:10.1007/s15035-009-0142-3
Robbins, P. F. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300045
“The increased availability of homeostatic cytokines (4, 5), along with the release of innate immune activators (6) observed after cytoreductive preparative regimens, has subsequently been found to play a significant role in enhancing the survival and function of adoptively trans-”
BackgroundRadiotherapy and Immunity – A Mini Review
Correa, R. (2012) · InTech eBooks · doi:10.5772/27361
“This phenomenon was associated with enhanced anti-tumor immunity in an adoptive transfer model (Paulos et al., 2007).”
BackgroundInnate immune activation enhances tumour immunotherapy
Bell, É. (2007) · Nature reviews. Immunology · doi:10.1038/nri2158
Los agentes infecciosos en la etiopatogenia de las enfermedades reumáticas
García-Lechuz, J. M. (2008) · Reumatología Clínica · doi:10.1016/s1699-258x(08)76165-5
Regulatory T Cells in the Control of Host-Microorganism
Belkaid, Y., & Tarbell, K. V. (2009)
DETERMINING THE MECHANISMS GENERATING SOLUBLE IL-15 COMPLEXES
Anthony, S. M. (2015) · Digital Commons-TMC (Texas Medical Center)
Microbiota Modulation of Myeloid Cells in Cancer
Goldszmid, R. S., Dzutsev, A., Viaud, S., Zitvogel, L., Restifo, N. P., & Trinchieri, G. (2015)
Self-citationCell-Based Immunotherapy for HCC: Our Experiences and Future Directions
Iida, N., Mizukoshi, E., & Kaneko, S. (2015) · Springer eBooks · doi:10.1007/978-4-431-55666-4_5
Taylor, N. N., Mondino, A., & Alarcón, B. (2014) · WORLD SCIENTIFIC eBooks · doi:10.1142/9789814295147_0001
Immunotherapy with Non–Genetically Modified T Cells
Yee, C. (2018) · Wiley eBooks · doi:10.1002/9781118684535.ch7
The Microbiota and Ovarian Cancer
Tanyi, J. L., & Facciabene, A. (2019) · Current cancer research · doi:10.1007/978-3-030-04155-7_11
Advances in the Application of Intestinal Flora in Anti-tumor Therapy
Wang, D., Wu, H., Liang, X., Liu, J. J., Li, H., & Xu, C. S. (2019) · journal of nutritional oncology · doi:10.34175/jno201902002
“In addition, RT can promote the transfer of adoptive T cells, the translocation of Gram-negative bacteria, and the release of lipopolysaccharides to activate the TLR4 signaling pathway of antigen-presenting cells [43].”
BackgroundCAR T-Cell Therapy for CNS Malignancies
Sanber, K. S., Joseph, S. K., & Ahmed, N. M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-66181-2.00012-3
Anticancer Immunotherapy: Prospects and Challenges
Sachdeva, R., Singh, P., Bose, A., Kalha, B., Sarkar, M., & Pal, R. (2019) · Springer eBooks · doi:10.1007/978-981-32-9816-3_8
Yang, D., Wang, X., Zhou, X., Wang, S., Zhao, J., Yang, H., Morse, M. A., Wu, J., Yuan, Y., Li, S., et al. (2020) · Research Square · doi:10.21203/rs.3.rs-136573/v1
Integrative Treatment of Lung Cancer Patients: Observational Study of 57 Cases
Anelli, L., Nardo, A. D., & Bonucci, M. (2021) · Asian Journal of Oncology · doi:10.1055/s-0040-1722380
Impact of Conditioning Regimen Choice: The Role of Dendritic Cells in Graft-Versus-Host Disease
Molina, M. S. (2021) · UA Campus Repository (The University of Arizona)
Godisela, K. K., Kiran, B. S. S., & Bramhachari, P. V. (2021) · Springer eBooks · doi:10.1007/978-981-16-3156-6_6
Innamarato, P. (2020) · Digital Commons - University of South Florida (University of South Florida)
Sharma, P., Subudhi, S. K., Peggs, K. S., Goswami, S., Gao, J., Quezada, S. A., & Allison, J. P. (2017) · Wiley eBooks · doi:10.1002/9781119000822.hfcm068
The Role of Langerin⁺ CD8α⁺ Dendritic Cells in Tumour Immunotherapy
Gibbins, J. D. (2014) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.17008219.v1
Biomarqueurs en immunothérapie, signatures moléculaires, radiomique : avons-nous avancé ?
Pabst, L., Lopes, S., Kotovskaya, M., Bertrand, B., & Mascaux, C. (2022) · Revue des Maladies Respiratoires Actualités · doi:10.1016/s1877-1203(22)00122-7
Geng, D., Zheng, L., Srivastava, R., Velasco‐Gonzalez, C., Riker, A. I., Markovic, S. N., & Dávila, E. (2023) · doi:10.1158/0008-5472.c.6500703
The microbiome and cancer immunotherapy
Niederhuber, J. E. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-87763-3.00020-4
A Review on Probiotics and Their Role in the Management of Cancer
Dahiya, R., Khan, S., & Kumar, S. (2024) · Current Probiotics · doi:10.2174/0126666499270987231218145156
Elwakil, B. H., & El‐Naggar, M. Y. (2024) · Springer eBooks · doi:10.1007/978-3-030-80962-1_382-1
Mohammadi, T., & Mohebalizadeh, M. (2023) · Springer eBooks · doi:10.1007/978-3-030-80962-1_373-1
Zheng, J. (2024) · Research Square · doi:10.21203/rs.3.rs-5277463/v1
Microbiome in Defence Against Cancer
Ramanathan, J. (2024) · Springer eBooks · doi:10.1007/978-3-031-70088-0_17
Gut microbiota affects aneurysms through biomechanical mechanisms: A mendelian randomization study
Li, R., Xu, Y., & Cheng, T. (2024) · Molecular & cellular biomechanics · doi:10.62617/mcb303
“The translocation of gut bacteria to the intraperitoneal space, due to epithelial layer damage, can induce transitory infection with systemic elevation of IL-12 [49].”
Kar, S., Verma, D., Mehrotra, S., & Prajapati, V. K. (2025) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2024.10.017
GUT MICROBIOME IN CANCER: THE NEXT BIG OPPORTUNITY FOR BETTER PATIENT OUTCOMES?
Povšin, J., Sotošek, T., Novak, M., & Breznik, B. (2025) · Slovenian Veterinary Research · doi:10.26873/svr-2029-2024
“For instance, lipopoly-saccharides (LPS) can activate Toll-like receptor 4 (TLR 4), which further enhances the T cell immune response against tumor cells (53).”
Gomaa, S., Nassef, M., Tabl, G. A., & Gabry, S. E. (2025) · Immunologic Research · doi:10.1007/s12026-025-09610-z
“This effect is specifically pronounced when vaccination occurs during both the lymphopenia and recovery phases following CTX treatment [22, 24, 50].”
Mousa, W. K., Ali, A., Abdelmoteleb, R. W. A., Shami, R. A., Alramadan, N., Moutraji, S. A., & Ghemrawi, R. (2025) · Targeted Cancer Therapy Connect · doi:10.69709/ciconnect.2025.154988
Villard, M., Espinosa-Carrasco, G., & Hernández, J. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.08.672311
Mohammadi, T., & Mohebalizadeh, M. (2025) · Springer eBooks · doi:10.1007/978-3-032-00759-9_373
Elwakil, B. H., & El‐Naggar, M. Y. (2025) · Springer eBooks · doi:10.1007/978-3-032-00761-2_382
The gut microbiome in B cell lymphoma
Vickers, D., Martynchyk, A., Henden, A. S., Smibert, O. C., Hawkes, E. A., & Chong, G. (2025) · Blood Reviews · doi:10.1016/j.blre.2025.101357
Chau, J., Yadav, M., Liu, B., Furqan, M., Dai, Q., Shahi, S., Gupta, A., Mercer, K. N., Eastman, E., Hejleh, T. A., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14978236
Chau, J., Yadav, M., Liu, B., Furqan, M., Dai, Q., Shahi, S., Gupta, A., Mercer, K. N., Eastman, E., Hejleh, T. A., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14978239
Chau, J., Yadav, M., Liu, B., Furqan, M., Dai, Q., Shahi, S., Gupta, A., Mercer, K. N., Eastman, E., Hejleh, T. A., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14978230
Chau, J., Yadav, M., Liu, B., Furqan, M., Dai, Q., Shahi, S., Gupta, A., Mercer, K. N., Eastman, E., Hejleh, T. A., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14978233
Chau, J., Yadav, M., Liu, B., Furqan, M., Dai, Q., Shahi, S., Gupta, A., Mercer, K. N., Eastman, E., Hejleh, T. A., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14978242
Cavalluzzo, B., Viuff, M. C., Tvingsholm, S. A., Ragone, C., Manolio, C., Mauriello, A., Buonaguro, F. M., Tornesello, M. L., Izzo, F., Morabito, A., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26695707
Calvet‐Mirabent, M., Tsukalov, I., Sánchez‐Cerrillo, I., Pino-Platas, J., Holmes-Anton, P. N., Agudo-Lera, M., Popova, O., González, R., García-Fraile, L. J., Lebrón-Romero, J. A., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.26.701473
Immunogénicite de la mort cellulaire induite par les chimiothérapies anti-cancéreuses
Aymeric, L. (2011) · theses.fr (ABES) · doi:10.70675/15e58e86z756bz4179z8fbbz6484931cb6da
Espinosa-Carrasco, G. (2016) · theses.fr (ABES) · doi:10.70675/f4c31cbcz110ez48dbza3eaz9a7512ef00fe
La souris humanisée : modèle d'étude de l'immunothérapie anti-cancer
Rochère, P. D. L. (2018) · theses.fr (ABES) · doi:10.70675/62c63415zab1az40e4z8c1fz0b5580505c4f
Diversité des macrophages dans un modèle murin de stéatohépatite non alcoolique
Tran, S. (2019) · theses.fr (ABES) · doi:10.70675/22efc884z2788z43fazabc1zaeb115ea6833
Probiotic-derived EPS-ZnO nanoparticles: therapeutic potential in colorectal cancer gene regulation
Afsharipoor, S., Nazari, R., Eghdami, A., Fasihi‐Ramandi, M., & Zolfaghari, M. R. (2026) · Cancer Cell International · doi:10.1186/s12935-026-04247-w
“Furthermore, studies have shown that molecules and metabolites derived from probiotics can prevent tumor progression by modulating the host’s immune system [20].”
Adrados, A., Pérez‐Fernández, J., García-Vicente, R., Garrote-de-Barros, A., Martínez‐López, J., Linares, M., & Hernández‐Sánchez, M. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1805129
“Early studies showed that antibiotic-in-duced depletion of commensal bacteria impaired adoptive cell transfer (ACT) ef fi cacy, partially recoverable by microbial ligands like LPS via TLR4 activation (248).”
Davar, D., Zarour, H. M., & Trinchieri, G. (2026) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-026-00916-y
Gouveia, L., Serpa, J., & Mendes, C. (2026) · Advances in experimental medicine and biology · doi:10.1007/978-3-032-12166-0_3
Chen, L., Bian, G., Qi, F., Cao, Y., Liao, X., Li, Q., Liang, H., Zhao, Z., Liu, X., Hoang, B. H., et al. (2026) · The Innovation Medicine · doi:10.59717/j.xinn-med.2026.100242
Exploring Endotoxemia in Age-Related Macular Degeneration, Glaucoma, and Diabetic Retinopathy
Larsen, P. P., Linard, M., Schweitzer, C., Delyfer, M., Korobelnik, J., Helmer, C., & Delcourt, C. (2026) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.67.10.14
The microbiome–EBV axis in carcinogenesis bridges commensal influence and viral oncogenesis
Tian, X., Ji, K., & Feng, M. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1909260
Microbiome-Mediated Mechanisms in Gastrointestinal Cancers
Das, H. K., Barman, P., & Konwar, R. (2026) · IGI Global eBooks · doi:10.4018/979-8-3373-3079-2.ch004
Modulating gut microbiome in cancer immunotherapy: Harnessing microbes to enhance treatment efficacy
Mishra, A., & Sahu, S. K. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-33206-7.00013-3
Turning cold tumors hot: Strategies to enhance antitumor immunity
Steffensen, V. G., Bratina, M., Tsiavou, C., Schmiegelow, K., & Zio, D. D. (2026) · The Journal of Experimental Medicine · doi:10.1084/jem.20260378
In Vivo Models of Allogeneic Hematopoietic Stem Cell Transplantation
Welniak, L. A., & Murphy, W. J. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-478-0_44
“increased immune responses including GVHD [20, 38, 39] and anti-tumor responses [ 21 ].”
BackgroundAllogeneic and Autologous Transplantation Therapy of Cancer: Converging Themes
Fowler, D. H. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-980-2_19
“And, second, adjuvant effects of inflammatory pathways activated through microbial translocation and TLR4 activation are clearly related to GVT effects and GVHD in the allogeneic transplantation context [6]; at the same time, their role in autologous immunotherapy has also now been identified [8].”
Background
Metadata
- Authors
- Paulos, C. M., Wrzesinski, C., Kaiser, Hinrichs, C. S., Chieppa, M., Cassard, L., Palmer, D. C., Boni, A., Muranski, P., Yu, Z., Gattinoni, L., Antony, P. A., Rosenberg, S. A., & Restifo, N. P.
- Affiliations
- National Institutes of Health (US)
- National Cancer Institute (US)
- Johns Hopkins University (US)
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2007-08-01
- Volume
- 117
- Issue
- 8
- Pages
- 2197-2204
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC1924500
- OpenAlex
- W2153512326
- Cited by
- 586
- References
- 63
- Citations by year
- 2026: 20 · 2025: 43 · 2024: 40 · 2023: 42 · 2022: 42 · 2021: 51 · 2020: 49 · 2019: 36 · 2018: 26 · 2017: 32 · 2016: 23 · 2015: 29 · 2014: 27 · 2013: 20 · 2012: 23
- FWCI
- 8.55
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- AIRUS (submittedVersion)
- Funders
- National Institutes of Health (Z99 CA999999)
- National Cancer Institute (Z01BC010763)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- microbial translocation, total body irradiation, lymphocyte depletion, adoptive T cell therapy, CD8+ T cells, TLR4 signaling, lipopolysaccharide, commensal gut microbiota, dendritic cell activation, inflammatory cytokines, cancer immunotherapy, B16F10 melanoma, vitiligo, CD14
- MeSH terms
- Animals, Anti-Bacterial Agents, Autoimmune Diseases, Intestines, Lipopolysaccharides, Lymphocyte Depletion, Lymphocyte Activation, Neoplasm Transplantation, Neoplasms, Experimental, Polymyxin B, Vitiligo, Whole-Body Irradiation, Signal Transduction, Autoimmunity, Cytokines, CD8-Positive T-Lymphocytes, Lipopolysaccharide Receptors, Bacterial Translocation, Adoptive Transfer, Cell Line, Tumor, Toll-Like Receptor 4, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
